1. Home
  2. OSS vs IKT Comparison

OSS vs IKT Comparison

Compare OSS & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo One Stop Systems Inc.

OSS

One Stop Systems Inc.

N/A

Current Price

$10.17

Market Cap

197.3M

Sector

Technology

ML Signal

N/A

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

N/A

Current Price

$1.98

Market Cap

201.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OSS
IKT
Founded
1998
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.3M
201.3M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
OSS
IKT
Price
$10.17
$1.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$8.50
$5.50
AVG Volume (30 Days)
1.3M
2.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
67.51
EPS
N/A
N/A
Revenue
$37,027,382.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
34.46
N/A
52 Week Low
$1.85
$1.33
52 Week High
$12.75
$2.58

Technical Indicators

Market Signals
Indicator
OSS
IKT
Relative Strength Index (RSI) 59.62 56.32
Support Level $9.75 $1.47
Resistance Level $10.74 $2.14
Average True Range (ATR) 0.67 0.16
MACD 0.14 0.00
Stochastic Oscillator 87.96 44.12

Price Performance

Historical Comparison
OSS
IKT

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.

Share on Social Networks: